Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00018447 · ClinicalTrials.gov registry record · Phase 2
Combination Osteogenic Therapy in Established Osteoporosis
A Phase 2 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00018447 is a Phase 2 study that has completed, run by US Department of Veterans Affairs.
The verdict
NCT00018447, a Phase 2 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
This study is designed to determine if combining parathyroid (PTH 1-34) with fluoride (MFPSR) therapy in a cyclic treatment regimen will: (1) produce a greater increase in bone density of the spine than would be produced by either treatment alone; (2) prevent the resistance (i.e., decreased bone formation and no further increase in bone density) that is observed within 18-24 months of PTH therapy; (3) eliminate the calcium deficiency and osteomalacia that can occur with fluoride; (4) prevent excessive bone fluoride content; and (5) result in an increase in bone density which is maintained after treatment is discontinued.
Interventions
- DRUG PTH 1-34
- DRUG MFPSR-fluoride
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-11 |
| Est. Completion | 2003-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00018447
The ClinicalTrials.gov registry entry for NCT00018447 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PTH 1-34 is the first listed.
NCT00018447 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00018447 about?
NCT00018447 is a clinical study titled "Combination Osteogenic Therapy in Established Osteoporosis". This study is designed to determine if combining parathyroid (PTH 1-34) with fluoride (MFPSR) therapy in a cyclic treatment regimen will: (1) produce a greater increase in bone density of the spine than would be produced by either treatment alone; (2) prevent the resistance (i.e., decreased bone for...
What is the current status of trial NCT00018447?
This trial is currently completed. It is a Phase 2 study. The study started on 1998-11. Estimated completion is 2003-10.
What interventions are being tested in trial NCT00018447?
The interventions under investigation include: PTH 1-34 (DRUG), MFPSR-fluoride (DRUG).
Who is sponsoring clinical trial NCT00018447?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.